We provide laboratory services to researchers requiring formalin-fixed, paraffin-embedded (FFPE) tumor tissue DNA molecular characterization. Our capability is supported by a fully automated platform for FFPE tissue DNA extraction, multiplex PCR-based targeted enrichment, library preparation, next-generation sequencing, and gene mutation analysis. This robust workflow increases traceability and reproducibility and improves the quality and efficacy of cancer mutation studies. Targeted sequencing of actionable mutations has important implications for cancer diagnosis, prognosis, treatment, and monitoring in the new era of personalized medicine.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
An interpretative report of cancer gene mutations will be provided. | |
|
|
|
|||||||||||||||||||
- Global : OEM@abnova.com / Japan : jutaku@funakoshi.co.jp
- TW : +886-2-8751-1888 / USA : +1(857) 639 0367 / Korea : +82-1670-5911.